Flanagan W. Michael

Chief Scientific Officer at Avidity Biosciences, Inc.

Sold, on record
$13.5M
Dollars the filings state
Form 4 sales
14
Latest Jan 21, 2026
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Avidity Biosciences, Inc.Routine
    Dec 18 2024

    Sold 12,742 shares at $32.66 ($416k)

    Flanagan W. Michael, CSTO

    10b5-1 planSold 14.9% of holdings ($2.8M position)72,647 shares left0.5x usual sizeFiling

  2. 2 Form 4 sale Avidity Biosciences, Inc.Routine
    Jan 21 +34 days

    Sold 5,672 shares at $28.60 ($162k)

    Flanagan W. Michael, Chief Scientific Officer

    10b5-1 planSold 5.8% of holdings ($2.8M position)91,975 shares left0.2x usual sizeFiling

  3. 3 Form 4 sale Avidity Biosciences, Inc.Routine
    Mar 11 +49 days

    Sold 20,000 shares at $30.13 ($603k)

    Flanagan W. Michael, Chief Scientific Officer

    10b5-1 planSold 17.9% of holdings ($3.4M position)91,975 shares left1.1x usual sizeFiling

  4. 4 Form 4 sale Avidity Biosciences, Inc.Routine
    Mar 20 +9 days

    Sold 11,780 shares at $31.06 ($366k)

    Flanagan W. Michael, Chief Scientific Officer

    10b5-1 planSold 12.8% of holdings ($2.9M position)80,195 shares left0.6x usual sizeFiling

  5. 5 Form 4 sale Avidity Biosciences, Inc.Routine
    Jun 11 +83 days

    Sold 20,000 shares at $32.88 ($658k)

    Flanagan W. Michael, Chief Scientific Officer

    10b5-1 planSold 20% of holdings ($3.3M position)80,195 shares left1.2x usual sizeFiling

  6. 6 Form 4 sale Avidity Biosciences, Inc.Routine
    Sep 11 +92 days

    Sold 20,000 shares at $38.94 ($779k)

    Flanagan W. Michael, Chief Scientific Officer

    10b5-1 planSold 20% of holdings ($3.9M position)80,195 shares left1x usual sizeFiling

  7. 7 Form 4 sale Avidity Biosciences, Inc.Routine
    Jan 7 +118 days

    Sold 2,373 shares at $72.23 ($171k)

    Flanagan W. Michael, Chief Scientific Officer

    10b5-1 planSold 2.5% of holdings ($6.8M position)91,627 shares left0.1x usual sizeFiling

  8. 8 Form 4 sale Avidity Biosciences, Inc.Routine
    Jan 21 +14 days

    Sold 6,534 shares at $72.45 ($473k)

    Flanagan W. Michael, Chief Scientific Officer

    10b5-1 planSold 7.1% of holdings ($6.6M position)85,093 shares left0.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Flanagan W. Michael
Source
Jan 21, 2026Avidity Biosciences, Inc.Chief Scientific OfficerForm 4 sale6,534$473k7.1%RoutineSEC
Jan 7, 2026Avidity Biosciences, Inc.Chief Scientific OfficerForm 4 sale2,373$171k2.5%RoutineSEC
Sep 11, 2025Avidity Biosciences, Inc.Chief Scientific OfficerForm 4 sale20,000$779k20.0%RoutineSEC
Jun 11, 2025Avidity Biosciences, Inc.Chief Scientific OfficerForm 4 sale20,000$658k20.0%RoutineSEC
Mar 20, 2025Avidity Biosciences, Inc.Chief Scientific OfficerForm 4 sale11,780$366k12.8%RoutineSEC
Mar 11, 2025Avidity Biosciences, Inc.Chief Scientific OfficerForm 4 sale20,000$603k17.9%RoutineSEC
Jan 21, 2025Avidity Biosciences, Inc.Chief Scientific OfficerForm 4 sale5,672$162k5.8%RoutineSEC
Dec 18, 2024Avidity Biosciences, Inc.CSTOForm 4 sale12,742$416k14.9%RoutineSEC
Dec 11, 2024Avidity Biosciences, Inc.CSTOForm 4 sale24,000$858k21.9%RoutineSEC
Dec 11, 2024Avidity Biosciences, Inc.OfficerForm 144 notice24,000$866kNoticeSEC
Oct 1, 2024Avidity Biosciences, Inc.CSTOForm 4 sale62,500$3M42.3%UnusualSEC
Sep 23, 2024Avidity Biosciences, Inc.CSTOForm 4 sale25,000$1.1M22.6%RoutineSEC
Sep 11, 2024Avidity Biosciences, Inc.CSTOForm 4 sale111,394$4.5M64.7%RoutineSEC
Jun 18, 2024Avidity Biosciences, Inc.CSTOForm 4 sale10,106$395k16.6%RoutineSEC
Jan 22, 2024Avidity Biosciences, Inc.CSTOForm 4 sale4,129$42k10.3%RoutineSEC